Nuveen’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
Other funds holding SKYE
BBA
Nuveen's SKYE Position: Q3 2026 in Review
Nuveen opened a new position in Skye Bioscience (SKYE) in Q3 2026: 295 shares worth $469. The stake represents ﹤0.01% of the portfolio and ranks #4989 among its holdings. This is a return to the name: Nuveen previously reported a position in SKYE as recently as Q1 2025.
Nuveen first reported a position in SKYE in Q2 2024 and has held it in 5 quarters since. The position peaked at $187K in Q2 2024. 31 funds tracked by Wall St. Rank hold SKYE as of Q3 2026.
- Nuveen held 295 shares of Skye Bioscience worth $469 as of Q3 2026.
- Skye Bioscience was a new Nuveen position in Q3 2026.
- Skye Bioscience made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4989 holding.
- Nuveen first reported a position in Skye Bioscience in Q2 2024 and has held it in 5 quarters since.
- Nuveen's Skye Bioscience position peaked at $187K in Q2 2024.
- 31 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2026.
Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.